demonstrated that the balance between proliferation and differentiation of adipocyte progenitor cells is regulated by intracellular oxidative stress. They reported that propofol, an anesthetic agent, that inhibits mitochondrial respiration and reduces oxidative stress, significantly increased preadipocyte differentiation by 125710%. Similar to propofol 6 and beside its receptor-mediated effects, clozapine is known to induce mitochondrial superoxide release, previously detected in neutrophils of patients under clozapine treatment, 8 and also seen in clozapinetreated preadipocytes. Additionally, the phenolic moiety of both molecules scavenges radicals. 9 Dalla Libera et al. 10 demonstrated that the antioxidant properties of clozapine are particularly effective in the hydrophobic environment of membranes and fat tissue. Furthermore, clozapine accumulates in adipose tissue (Novartis, personal communication), where the concentration of the drug might be even higher than the 5 mM used in this study.
In line with the results of Carriere 6,7 and Galinier et al.
11 who found obesity associated with reduced oxidative stress, we propose that the reduced redox state under clozapine-and propofol-treatment favours preadipocyte differentiation probably independent from receptor-activated pathways. Therefore longterm clozapine-treatment causes a steady proliferation of preadipocytes and neoformation of adipocytes leading to permanent weight gain.
Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors It has been proposed that schizophrenia susceptibility genes converge upon synapses 1,2 and glutamate, [1] [2] [3] [4] impacting particularly on N-methyl-D-aspartate receptor (NMDAR) signalling. 1, 2, 4 One of the problems with the proposition concerns the prior probability that it is true. Much of the genome is expressed in the brain, many genes encode synaptic proteins, 5 many synapses utilize glutamate, 6 and most of these contain NMDARs. 7 Thus, the proposition is inherently weak, as any randomly selected group of genes is likely to include a large fraction that converge on synapses, glutamate and NMDARs. This is akin to the 'six degrees of separation', postulated by Karinthy in 1929 regarding the relatedness of individuals, and recently extended not only to computational science and entertainment domains, but becoming relevant biologically as the extent of molecular interactions in biochemical pathways becomes apparent, and the concept of the 'interactome' emerges. 8, 9 Here, we report a crude bioinformatics approach to assess the prior likelihood that schizophrenia genes would appear to converge on synapses, glutamate or NMDARs. We then show that the convergence is indeed greater than would have been expected by chance.
Two hundred and seven genes were randomly selected (nine at intervals along each autosome and X chromosome) using the UCSC Human Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway) by someone (VAW) with no knowledge of schizophrenia genetics or the hypothesis being investigated. Alternative names for each gene were collated via links from this website. This list of terms was entered into a Medline search (to June 2006) for papers containing, in the title, abstract, or keyword list: {(gene name) AND (synapse OR synaptic OR glutamate OR NMDA)}. The abstracts of all papers thus identified (range: 0-1136) were then read and rated (by PJH) as to whether they provide data showing (1) a synaptic function or localization of the gene product, (2) an effect on glutamate transmission, which is not clearly exceeded by an effect on another neurotransmitter and (3) an influence on NMDAR expression or signalling. If the abstract was ambiguous, the whole paper was read; where ambiguity remained, rating erred on the side of inclusiveness (i.e. toward the null hypothesis). No attempt was made to quantify the evidence linking each gene to each parameter, merely to ascertain that there was at least one paper reporting such a link. For a list of the genes and their ratings, see Supplementary Material.
Of the genes, 20.8% (43/207) were rated as synaptic, 10.1% (21/207) were glutamatergic and 6.3% (13/207) were NMDAR-related. We then used Fisher's exact test to assess whether these figures differ from those for schizophrenia susceptibility genes. For this purpose, we chose the seven schizophrenia genes that met the robustness criterion of at least three independent positive studies (a ' þ þ þ ' rating) in Table 1 of Harrison and Weinberger. 2 All seven genes (neuregulin, dysbindin, RGS4, DISC1, COMT, G72/DAOA and GRM3) were considered synaptic, five glutamatergic (not COMT or DISC1) and three to impact NMDAR signalling (not RGS4, DISC1, COMT or dysbindin); see Supplementary Material. The comparison was significant for all three parameters; that is, more schizophrenia susceptibility genes than expected based on the randomly selected genes were rated synaptic (P < 0.0001), glutamatergic (P = 0.0003) and NMDAR-related (P = 0.0101) ( Table 1) .
Our analysis supports the notion that schizophrenia genes converge upon synapses, glutamate and NMDAR signalling. As such, the proposal has some validity, and suggests a genetic basis to pre-existing theories of synaptic, glutamatergic and NMDAR involvement in the disease pathophysiology. 2, 4, 10 There are of course major caveats to our findings. (1) The number of randomly selected genes rated positive for each criterion may be an underestimate, as only the title, abstract or keywords of articles were searched; data embedded in the full text will have been missed. Moreover, there is a degree of subjectivity involved in the ratings. (2) As research proceeds, novel functions may be discovered that render additional genes positive for the criteria (although this also applies to susceptibility genes). (3) Controversy remains as to how many true schizophrenia genes have been identified and thus should have been included in the comparison. However, a large proportion of the other putative susceptibility genes (e.g. DAAO, CAPON, Akt1 and DRD2) also meet one or more of the criteria, so we doubt that our findings would change dramatically if an extended list were chosen. (4) Arguably, schizophrenia genes identified from a candidate gene approach (rather than from cytogenetics or positional cloning), viz GRM3, should have been excluded, as its candidacy arose in part from prior theories about glutamate; omission of GRM3 renders the NMDAR comparison a trend (P = 0.059) but those for synapses and glutamate remain significant (both P < 0.002). Hence, despite its preliminary nature, our analysis suggests that there may be a synaptic and glutamate/ NMDAR 'signature' of schizophrenia susceptibility genes. It remains to be seen whether this apparent convergence ultimately proves important, trivial or epiphenomenal. Letters to the Editor
